What is the proper administration and dosage of a D10 (10% dextrose solution) infusion for treating hypoglycemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

D10 Infusion for Hypoglycemia

For treating hypoglycemia with D10 (10% dextrose), administer 5-10 gram aliquots (50-100 mL) intravenously every 1-2 minutes until symptoms resolve, rather than giving a single large bolus, with a target post-treatment glucose of 100-180 mg/dL. 1

Initial Treatment Protocol

Titrated dosing is superior to bolus administration:

  • Give 5-10 grams of dextrose as D10 (50-100 mL) every 1-2 minutes until the patient becomes alert and symptomatic hypoglycemia resolves 1
  • This approach corrects blood glucose into the target range in 98% of patients within 30 minutes while avoiding dangerous overcorrection 1
  • A patient-specific formula can guide dosing: (100 − current blood glucose in mg/dL) × 0.2 grams = total dose of dextrose needed 1

For continuous infusion in insulin overdose or prolonged hypoglycemia:

  • Start D10 at 100 mL/kg per 24 hours (approximately 4.2 mL/kg/hour or 7 mg/kg/minute) 2
  • Titrate the infusion rate to maintain blood glucose between 100-180 mg/dL 2

Critical Monitoring Requirements

Immediate monitoring:

  • Recheck blood glucose 15 minutes after initial treatment, as additional doses are frequently needed 1
  • Repeat glucose measurement at 60 minutes, as the effect may be temporary 1

During continuous infusion:

  • Monitor blood glucose every 1-2 hours during any ongoing dextrose infusion 1, 2
  • Check serum potassium and sodium levels carefully, as dextrose administration can cause electrolyte shifts 2
  • Monitor every 30-60 minutes initially when starting continuous infusion 2

Advantages of D10 Over D50

D10 demonstrates superior safety profile:

  • No extravasation injuries reported with D10 (0/1057 patients) compared to 13/310 adverse events with D50 3
  • Lower post-treatment glucose levels: 6.2 mmol/L with D10 versus 8.5-9.4 mmol/L with D50 4, 3
  • Median total dose administered is significantly lower with D10 (10 grams) compared to D50 (25 grams) 4, 5

Efficacy is equivalent or superior:

  • Symptom resolution rates: 95.9% with D10 versus 88.8% with D50 3
  • Complete resolution of hypoglycemia: 99.2% with D10 versus 98.7% with D50 3
  • Time to achieve Glasgow Coma Scale of 15 is similar (6-8 minutes) across concentrations 4, 5

Important Caveats and Pitfalls

Avoid reflexive full-dose administration:

  • Do not automatically give 25 grams of dextrose—this causes excessive blood glucose elevation and has been associated with cardiac arrest and hyperkalemia when given rapidly and repeatedly 1
  • Titrate based on initial glucose level and patient response rather than administering fixed large doses 1

Prevent rebound hypoglycemia:

  • Never abruptly discontinue dextrose infusion in insulin overdose patients 2
  • Reduce infusion rate by 50% over the final 30 minutes before discontinuing to prevent rebound 2

Additional dose requirements:

  • Approximately 20-23% of patients require a second dose of D10 3, 6
  • This is higher than D50 (8.1%), but the trade-off is improved safety and lower post-treatment hyperglycemia 3

Maximum Infusion Rates

Per FDA labeling:

  • The maximum rate at which dextrose can be infused without producing glycosuria is 0.5 g/kg/hour 7
  • About 95% of dextrose is retained when infused at 0.8 g/kg/hour 7

Special Populations

Pediatric dosing:

  • Children require 15-20 grams of glucose for moderate hypoglycemia 1
  • For pediatric patients, D5W should be administered as a constant infusion at 100 mL/kg per 24 hours (approximately 7 mg/kg/min) with appropriate maintenance electrolytes 8

Patients unable to swallow:

  • IV dextrose is preferred over glucagon due to faster response time 1
  • For conscious patients able to swallow, oral glucose is first-line treatment 9

References

Guideline

D50 Dosing for Hypoglycemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

D5NS Infusion Rate for Insulin Overdose-Induced Hypoglycemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

IV 5% Dextrose Administration for Starvation Ketosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.